Some authors have found that EGFR mutation is a significant predictor of overall survival and relapse-free survival in surgically resected adenocarcinoma (44, 45), while others showed that EGFR mutation was insignificant for post-surgical survival (46). This evidence concerns the gene EGFR and adenocarcinoma.